INVO Fertility Expects Combined Pro Forma Annualized Revenue Run Rate Of ~$9M
Benzinga Newsdesk 9 months ago
News
INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today
INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today issued a shareholder letter from its Chief Executive Officer, Steve Shum, outlining the Company's strengthened fundamental position and its strategic outlook for continued growth.
In the letter, management highlights meaningful progress across operations, acquisitions, and capital structure, positioning INVO Fertility for growth through both organic initiatives and strategic clinic acquisitions.